12:00 AM
May 17, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Rubitecan RFS 2000 oral 9-nitrocamptothecin: Phase I/II testing update

SUPG also began U.S. Phase I testing of rubitecan in combination with Eli Lilly and Co.'s ...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >